Literature DB >> 9191543

Rapid and large-scale method to detect K-ras gene mutations in tumor samples.

E Lopez-Crapez1, C Chypre, J Saavedra, J Marchand, J Grenier.   

Abstract

We have developed a rapid and large-scale method for the detection of K-ras gene mutations in tumors. First, DNA is amplified by an asymmetric PCR; second, the single-strand dinitrophenyl (DNP)-labeled amplified DNA is hybridized specifically to oligonucleotide probes affixed on a tube. Finally, perfectly matched duplexes are easily detected by a monoclonal anti-DNP antibody bearing 125I. The usefulness of this technique is illustrated by analyzing K-ras codon 12 mutations in human colorectal samples. This reliable assay procedure can be applied to the rapid screening of virtually any genetic disease caused by previously described point mutations.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9191543

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  10 in total

1.  A homogeneous europium cryptate-based assay for the diagnosis of mutations by time-resolved fluorescence resonance energy transfer.

Authors:  E Lopez-Crapez; H Bazin; E Andre; J Noletti; J Grenier; G Mathis
Journal:  Nucleic Acids Res       Date:  2001-07-15       Impact factor: 16.971

2.  Wnt/β-catenin signaling accelerates mouse lung tumorigenesis by imposing an embryonic distal progenitor phenotype on lung epithelium.

Authors:  Eugenia C Pacheco-Pinedo; Amy C Durham; Kathleen M Stewart; Ashley M Goss; Min Min Lu; Francesco J Demayo; Edward E Morrisey
Journal:  J Clin Invest       Date:  2011-04-01       Impact factor: 14.808

3.  Src tyrosine kinase inhibits apoptosis through the Erk1/2- dependent degradation of the death accelerator Bik.

Authors:  J Lopez; C Hesling; J Prudent; N Popgeorgiev; R Gadet; I Mikaelian; R Rimokh; G Gillet; P Gonzalo
Journal:  Cell Death Differ       Date:  2012-03-02       Impact factor: 15.828

4.  The non-crosslinking fixative RCL2®-CS100 is compatible with both pathology diagnosis and molecular analyses.

Authors:  Florence Boissière-Michot; Amélie Denouël; Nathalie Boulle; Carole Guillaume; Béatrice Orsetti; Evelyne Lopez-Crapez; Marie-Christine Chateau; Frédéric Bibeau
Journal:  Pathol Oncol Res       Date:  2012-08-15       Impact factor: 3.201

5.  Active macropinocytosis induction by stimulation of epidermal growth factor receptor and oncogenic Ras expression potentiates cellular uptake efficacy of exosomes.

Authors:  Ikuhiko Nakase; Nahoko Bailey Kobayashi; Tomoka Takatani-Nakase; Tetsuhiko Yoshida
Journal:  Sci Rep       Date:  2015-06-03       Impact factor: 4.379

6.  Contextual inhibition of fatty acid synthesis by metformin involves glucose-derived acetyl-CoA and cholesterol in pancreatic tumor cells.

Authors:  Mary Jo Cantoria; László G Boros; Emmanuelle J Meuillet
Journal:  Metabolomics       Date:  2013-06-26       Impact factor: 4.290

7.  Lipoprotein-biomimetic nanostructure enables efficient targeting delivery of siRNA to Ras-activated glioblastoma cells via macropinocytosis.

Authors:  Jia-Lin Huang; Gan Jiang; Qing-Xiang Song; Xiao Gu; Meng Hu; Xiao-Lin Wang; Hua-Hua Song; Le-Pei Chen; Ying-Ying Lin; Di Jiang; Jun Chen; Jun-Feng Feng; Yong-Ming Qiu; Ji-Yao Jiang; Xin-Guo Jiang; Hong-Zhuan Chen; Xiao-Ling Gao
Journal:  Nat Commun       Date:  2017-05-10       Impact factor: 14.919

8.  Identification of anti-tumour biologics using primary tumour models, 3-D phenotypic screening and image-based multi-parametric profiling.

Authors:  Alan M Sandercock; Steven Rust; Sandrine Guillard; Kris F Sachsenmeier; Nick Holoweckyj; Carl Hay; Matt Flynn; Qihui Huang; Kuan Yan; Bram Herpers; Leo S Price; Jo Soden; Jim Freeth; Lutz Jermutus; Robert Hollingsworth; Ralph Minter
Journal:  Mol Cancer       Date:  2015-07-31       Impact factor: 27.401

9.  Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells.

Authors:  Cosimo Commisso; Shawn M Davidson; Rengin G Soydaner-Azeloglu; Seth J Parker; Jurre J Kamphorst; Sean Hackett; Elda Grabocka; Michel Nofal; Jeffrey A Drebin; Craig B Thompson; Joshua D Rabinowitz; Christian M Metallo; Matthew G Vander Heiden; Dafna Bar-Sagi
Journal:  Nature       Date:  2013-05-12       Impact factor: 49.962

10.  An ultra-stable cytoplasmic antibody engineered for in vivo applications.

Authors:  Hiroyuki Kabayama; Makoto Takeuchi; Naoko Tokushige; Shin-Ichi Muramatsu; Miyuki Kabayama; Mitsunori Fukuda; Yoshiyuki Yamada; Katsuhiko Mikoshiba
Journal:  Nat Commun       Date:  2020-01-17       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.